Chargement de la fiche…
rhumatologie
Pr Patrick Mismetti
Hospitalo-universitaire
Saint-Priest-en-Jarez (42277)
Essai clinique · Épidémiologie & registres · Vraie vie / RWE
0Publications
0Thèses dirigées
0Vidéos
0Citations de la publi la +
EnseignementExpérience confirmée
Après la consultation, le Pr Patrick Mismetti peut vous remettre une sélection de ressources adaptée à votre pathologie. Vous avez reçu un code ? Saisissez-le →
Ce qu'il est utile d'apporter à votre rendez-vous avec le Pr Patrick Mismetti. Cochez au fur et à mesure — la liste vous suit sur toutes les fiches.
Documents / notes
Examens à apporter
Traitement
Pourquoi consulter Pr Patrick Mismetti
- Auteur de référence en rhumatologie
- Encadrant universitaire
- Conseils vidéo gratuits
- Expérience confirmée
- Délais de RDV courts dans la région
Tout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
Dernières publications
Publications les plus citées
143 citationsRivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial2022 · ChestPubMed ↗132 citationsPlatelets as Key Factors in Inflammation: Focus on CD40L/CD402022 · Frontiers in immunologyPubMed ↗127 citationsExtended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism2025 · The New England journal of medicinePubMed ↗
Diplômes & qualifications
DES
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'Études Spécialisées
CES
DE Docteur en médecine — Capacité / Certificat d'Études Spéciales
Lieu d'exercice
Domaines d'expertise
Essai cliniqueÉpidémiologie & registresVraie vie / RWEGériatriePharmacovigilance
Transversal
422026European heart journal. Cardiovascular pharmacotherapy
PubMed ↗API-CAT Investigators' Decisions on Anticoagulation following Extended Treatment for Cancer VTE
2026Research and practice in thrombosis and haemostasis
PubMed ↗Impact of adherence to elastic compression stockings on efficacy to prevent postthrombotic syndrome: a prespecified analysis of the Compression Elastique Evaluation du Syndrome post Thrombotique study
2026Blood advances
PubMed ↗Complications in Cancer Associated Thrombosis patients on tinzaparin by cancer site and frailty: a pooled analysis
2025Thrombosis and haemostasis
PubMed ↗Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling Study
2025Anaesthesia, critical care & pain medicine
PubMed ↗Anticoagulant management in Emergency settings: 2024 guidelines from the French Society of Emergency Medicine (SFMU), the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Working Group on Perioperative Haemostasis (GIHP), endorsed by the French Neurovascular Society
2025Archives of cardiovascular diseases
PubMed ↗The management of cancer-associated thromboembolism: Proposals from the French multidisciplinary INNOVTE CAT Working Group
2025The New England journal of medicine
PubMed ↗Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
2025European journal of internal medicine
PubMed ↗Prevention of venous thromboembolism in critically ill patients: current state and future perspectives
2024La Revue de medecine interne
PubMed ↗[Translation into French and republication of: "Cancer-related arterial thromboembolic events"]
2024Archives of cardiovascular diseases
PubMed ↗Cancer-related arterial thromboembolic events
2024Archives of cardiovascular diseases
PubMed ↗Anticoagulant treatment of cancer-associated thromboembolism
2024Archives of cardiovascular diseases
PubMed ↗Management of cancer-associated thromboembolism: Introduction
2024Journal of thrombosis and haemostasis : JTH
PubMed ↗Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study
2024Fundamental & clinical pharmacology
PubMed ↗Latest advances in the reversal strategies for direct oral anticoagulants
2024Anaesthesia, critical care & pain medicine
PubMed ↗Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
2024Archives of cardiovascular diseases
PubMed ↗Management of cancer-associated thromboembolism in vulnerable population
2023Respiratory medicine and research
PubMed ↗French guidelines for the treatment of cancer-associated venous thromboembolism - 2023 update
2023International journal of molecular sciences
PubMed ↗Inhibition of Factor XI: A New Era in the Treatment of Venous Thromboembolism in Cancer Patients?
2023Current research in translational medicine
PubMed ↗Primary prevention of cancer-associated venous thrombosis: Rationale and challenges in clinical practice
2023Clinical and translational science
PubMed ↗Plasma lipidomic analysis to investigate putative biomarkers of P-glycoprotein activity in healthy volunteers
2023Thrombosis research
PubMed ↗Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial
2022Expert opinion on drug metabolism & toxicology
PubMed ↗The impact of advanced age on anticoagulant therapy for acute venous thromboembolism
2022Journal of thrombosis and haemostasis : JTH
PubMed ↗Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studies
2022Vascular and endovascular surgery
PubMed ↗Pathological Analysis and Clinical Evolution After Radiological Removal of Retrievable Vena Cava Filters
2022Medicina (Kaunas, Lithuania)
PubMed ↗Cardiac Biomarkers in Patients with Acute Pulmonary Embolism
2022BMJ open
PubMed ↗Platelet transmission electron microscopy for the assessment of poor biological response to antiplatelet agent: pilot descriptive and prospective study - ELECTROSTROKE
2022Frontiers in immunology
PubMed ↗Platelets as Key Factors in Inflammation: Focus on CD40L/CD40
2022The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
PubMed ↗Using 99mTc-(V)-DMSA to follow the vascular calcification process in vascular smooth muscle cells based on pit-1 expression
2022Journal of clinical medicine
PubMed ↗Pulmonary Embolism in the Cancer Associated Thrombosis Landscape
2022Cancers
PubMed ↗Management of Cancer-Associated Thrombosis in France: A National Survey among Vascular Disease and Supportive Care Specialists
2021Virology journal
PubMed ↗Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection
2021Thrombosis research
PubMed ↗Opinion and practice survey about the use of prognostic models in acute pulmonary embolism
2021Frontiers in immunology
PubMed ↗The Non-Haemostatic Response of Platelets to Stress: An Actor of the Inflammatory Environment on Regenerative Medicine?
2021Thrombosis research
PubMed ↗Recovery from acute kidney injury in patients with pulmonary embolism: A single-center study
2021Hamostaseologie
PubMed ↗Effects and Side Effects of Platelet Transfusion
2021Thrombosis research
PubMed ↗In memory of Professor Guy Meyer, 1957-2020
2021Therapeutic drug monitoring
PubMed ↗Severe Inflammation, Acute Kidney Injury, and Drug-Drug Interaction: Triple Penalty for Prolonged Elimination of Apixaban in Patients With Coronavirus Disease 2019: A Grand Round
2021Journal of thrombosis and haemostasis : JTH
PubMed ↗An epidemic of redundant meta-analyses
2021International journal of molecular sciences
PubMed ↗Platelet Innate Immune Receptors and TLRs: A Double-Edged Sword
2021Vascular pharmacology
PubMed ↗Thromboprophylaxis strategies to improve the prognosis of COVID-19
2021Journal of cancer research and clinical oncology
PubMed ↗Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma
2021Thrombosis research
PubMed ↗Management of acute venous thromboembolism in patients taking antiplatelet therapy
Essai clinique
72026Circulation
PubMed ↗Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial
2026The Lancet. Haematology
PubMed ↗Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial
2025Lancet (London, England)
PubMed ↗Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial
2023EClinicalMedicine
PubMed ↗Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial
2023NEJM evidence
PubMed ↗Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical Patients
2022Chest
PubMed ↗Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial
2021Journal of clinical epidemiology
PubMed ↗Compared to randomized studies, observational studies may overestimate the effectiveness of DOACs: a metaepidemiological approach
Épidémiologie & registres
22024Presse medicale (Paris, France : 1983)
PubMed ↗Elderly patients with venous thromboembolism: Insights from the RIETE registry
2022American journal of cardiovascular drugs : drugs, devices, and other interventions
PubMed ↗Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
Vraie vie / RWE
22022American journal of cardiovascular drugs : drugs, devices, and other interventions
PubMed ↗Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
2021Journal of clinical epidemiology
PubMed ↗Compared to randomized studies, observational studies may overestimate the effectiveness of DOACs: a metaepidemiological approach
Gériatrie
12024Presse medicale (Paris, France : 1983)
PubMed ↗Elderly patients with venous thromboembolism: Insights from the RIETE registry
Pharmacovigilance
12022American journal of cardiovascular drugs : drugs, devices, and other interventions
PubMed ↗Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
Revue / méta-analyse
12026Research and practice in thrombosis and haemostasis
PubMed ↗The Ottawa score for prediction of recurrent venous thromboembolism in cancer patients treated with tinzaparin: an individual patient data meta-analysis
Publications HAL
82026Article
Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial
Circulation
2025Article
Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling Study
Thrombosis and Haemostasis
2025Article
Apixaban or rivaroxaban for extended anticoagulation in patients with venous thromboembolism: A post hoc analysis of the renove clinical trial
Blood
2025Article
Role of platelet α2-adrenoreceptor in biological low response to Clopidogrel for patients with non cardioembolic ischemic stroke or transient ischemic attack
American Journal of Translational Research
2025Article
Monitoring of biological response to clopidogrel after treatment for non-cardioembolic ischemic stroke or transient ischemic attack
American Journal of Translational Research
2025Article
Anticoagulant management in emergency settings: 2024 guidelines from the French Society of Emergency Medicine (SFMU), the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Working Group on Perioperative Haemostasis (GIHP)*
Anaesthesia Critical Care & Pain Medicine
2025Article
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
New England Journal of Medicine
2025Article
Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial
The Lancet
Thèse
22001Lyon 1
Modélisation pharmacocinétique-pharmacodynamique par approche de population de deux antivitamines K, l'Acénocoumarol et la Warfarine : influence de l'éducation des malades et de l'observance au traitement sur la stabilité pharmacodynamique
Pharmacologie
1990Saint-Etienne
Interet de l'hemodilution normovolemique et de la section per-operatoire de l'arcade du soleaire : dans la prevention des thromboses veineuses profondes post-operatoires de la chirurgie du genou ; a propos d'un travail retrospectif portant sur 122 malades du service orthopedie du professeur g. bousquet a saint-etienne
Médecine
Direction de thèses
6Encadrement de doctorants — signal d'activité universitaire.
2017Doctorant : Farès Moustafa
Risque hémoragique sous anticoagulants : Vers une prise en charge personnalisée
Lyon
2013Doctorant : Marianne Sarazin
Elaboration d'un score de vieillissement : propositions théoriques
Saint-Etienne
2011Doctorant : Cyrille Renaud
L'infarctus cérébral artériel du nouveau-né à terme : présentation clinique, facteurs de risques et déterminants évolutifs à partir d'une cohorte prospective multicentrique d'épidémiologie descriptive
Saint-Etienne
2011Doctorant : Laurent Bertoletti
Prise en charge diagnostique et thérapeutique des patients suspects d'embolie pulmonaire : problématique particulière en cas de Broncho-Pneumopathie Chronique Obstructive
Saint-Etienne
2010Doctorant : Alice Lorans
Dénutrition en cancérologie : repérage des patients à risque
Saint-Etienne
2009Doctorant : Céline Chauleur
Identification des facteurs de risque pour prévenir les complications thrombotiques et hémorragiques de la grossesse
Saint-Etienne
Données issues de l'Annuaire Santé (ANS) — Licence Ouverte 2.0. Enrichissements à partir de sources publiques. Vous êtes le praticien référencé ? Faites corriger ou retirer votre fiche : demande de rectification ou de retrait.